Yair Lotan Selected Research

Yair Lotan Research Topics

Disease

182	Neoplasms (Cancer) 02/2024 - 01/2002
170	Urinary Bladder Neoplasms (Bladder Cancer) 03/2024 - 01/2002
149	Carcinoma (Carcinomatosis) 07/2023 - 02/2004
51	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 06/2004
30	Non-Muscle Invasive Bladder Neoplasms 02/2024 - 09/2009
28	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2004
26	Lymphatic Metastasis 05/2023 - 02/2004
25	Renal Cell Carcinoma (Grawitz Tumor) 02/2023 - 10/2006
20	Transitional Cell Carcinoma 04/2014 - 01/2002
19	Margins of Excision 01/2023 - 06/2004
17	Carcinoma in Situ 01/2017 - 09/2006
15	Disease Progression 02/2024 - 02/2004
10	Hematuria 01/2023 - 07/2010
8	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019 - 03/2011
6	Infections 10/2023 - 11/2003
6	Adenocarcinoma 11/2018 - 05/2007
6	Shock 07/2011 - 04/2002
5	Kidney Neoplasms (Kidney Cancer) 12/2020 - 08/2012
5	Extranodal Extension 10/2014 - 06/2004
5	Carcinogenesis 06/2014 - 11/2007
5	Obesity 01/2014 - 05/2008
4	Pain (Aches) 12/2019 - 09/2009
4	Necrosis 01/2017 - 11/2015
3	Aneuploidy (Aneuploid) 01/2023 - 10/2008
3	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 06/2021 - 01/2020
3	Hydronephrosis 01/2021 - 01/2011
3	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2021 - 11/2005
3	Testicular Neoplasms (Testicular Cancer) 01/2018 - 11/2002
3	Diabetes Mellitus 08/2014 - 12/2013
3	Urolithiasis 07/2011 - 06/2008
3	Hemorrhage 08/2005 - 06/2002
2	COVID-19 12/2023 - 12/2020
2	Pathologic Constriction (Stenosis) 01/2023 - 01/2021

Drug/Important Bio-Agent (IBA)

69	Biomarkers (Surrogate Marker)IBA 02/2023 - 11/2005
21	Prostate-Specific Antigen (Semenogelase)IBA 01/2022 - 06/2004
16	Proteins (Proteins, Gene)FDA Link 02/2023 - 05/2007
15	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 06/2008
14	Tumor Biomarkers (Tumor Markers)IBA 02/2023 - 01/2002
14	nuclear matrix protein 22IBA 04/2016 - 05/2005
10	SurvivinIBA 11/2015 - 02/2004
9	Phenobarbital (Luminal)FDA Link 01/2022 - 01/2019
8	DNA (Deoxyribonucleic Acid)IBA 02/2023 - 07/2011
7	Messenger RNA (mRNA)IBA 02/2024 - 08/2014
7	5-aminolevulinic acid hexyl ester FDA Link 01/2022 - 01/2018
6	LipidsIBA 06/2022 - 12/2015
6	CyclinsIBA 11/2016 - 12/2006
5	EnzymesIBA 11/2019 - 03/2011
4	Gemcitabine FDA Link 05/2023 - 06/2008
4	Glucose (Dextrose)FDA LinkGeneric 02/2023 - 09/2017
4	RNA (Ribonucleic Acid)IBA 02/2023 - 08/2017
4	Indicators and Reagents (Reagents)IBA 01/2023 - 08/2010
4	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2023 - 01/2018
4	AndrogensIBA 01/2020 - 08/2013
4	Finasteride (Propecia)FDA LinkGeneric 05/2016 - 03/2005
4	Cyclin EIBA 01/2015 - 03/2011
3	Dihydrotachysterol (AT 10)IBA 12/2023 - 11/2013
3	Tricarboxylic AcidsIBA 02/2023 - 09/2017
3	NucleotidesIBA 01/2023 - 09/2017
3	PlatinumIBA 01/2022 - 10/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 04/2015
3	Immune Checkpoint InhibitorsIBA 10/2021 - 01/2017
3	MicroRNAs (MicroRNA)IBA 04/2021 - 12/2015
3	hydrogen sulfite (bisulfite)IBA 11/2019 - 07/2011
3	Caveolin 1IBA 01/2019 - 05/2007
3	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2016 - 06/2008
3	Methotrexate (Mexate)FDA LinkGeneric 04/2016 - 06/2008
3	Vinblastine (Vinblastine Sulfate)FDA Link 04/2016 - 06/2008
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2015 - 07/2013
3	AntigensIBA 04/2015 - 09/2013
3	TOR Serine-Threonine KinasesIBA 01/2015 - 03/2013
3	Metformin (Glucophage)FDA LinkGeneric 08/2014 - 12/2013
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2011 - 03/2007
3	Hemostatics (Antihemorrhagics)IBA 08/2005 - 06/2002
2	Interleukin-6 (Interleukin 6)IBA 02/2024 - 01/2022
2	Carboplatin (JM8)FDA LinkGeneric 05/2023 - 11/2022
2	Interleukin-8 (Interleukin 8)IBA 01/2023 - 04/2021
2	mesoglycanIBA 01/2023 - 07/2015
2	Formaldehyde (Formol)FDA Link 01/2023 - 03/2018

Therapy/Procedure

122	Cystectomy 03/2024 - 09/2005
77	Therapeutics 02/2024 - 06/2004
60	Nephroureterectomy 07/2023 - 07/2008
40	Lymph Node Excision (Lymph Node Dissection) 03/2024 - 11/2002
38	Drug Therapy (Chemotherapy) 03/2024 - 12/2006
33	Neoadjuvant Therapy 03/2024 - 10/2006
30	Prostatectomy (Retropubic Prostatectomy) 01/2021 - 06/2004
28	Adjuvant Chemotherapy 01/2021 - 10/2006
20	Radiotherapy 11/2021 - 02/2006
17	Nephrectomy 01/2021 - 04/2004
12	Immunotherapy 01/2022 - 10/2012
8	Transurethral Resection of Bladder 12/2023 - 11/2016
7	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 12/2012 - 04/2002
5	Radiofrequency Ablation 01/2016 - 12/2003
4	Length of Stay 01/2020 - 11/2002
3	Induction Chemotherapy 03/2024 - 01/2016
3	Aftercare (After-Treatment) 01/2021 - 05/2006
3	Adjuvant Radiotherapy 08/2017 - 10/2006
3	Chemoprevention 02/2011 - 08/2006
3	Operative Surgical Procedures 09/2009 - 11/2004
3	Lasers (Laser) 08/2007 - 06/2002
2	Stents 01/2023 - 01/2021